Studying the mechanisms of ladasten action

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 68, Issue 3, 2005, Pages 3-6

  Yarkova, M A ^a   Voronin, M V ^a   Seredenin, S B ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADAMANTANE DERIVATIVE; BENZODIAZEPINE; DIAZEPAM; N (2 ADAMANTYL) N (4 BROMOPHENYL)AMINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMOTIONAL STRESS; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; RAT; TRANQUILIZING ACTIVITY;

ADAMANTANE; ANIMALS; ANTI-ANXIETY AGENTS; ASTHENIA; BEHAVIOR, ANIMAL; BRAIN; DIAZEPAM; MALE; RATS; RATS, INBRED STRAINS; RECEPTORS, GABA-A; STRESS, PSYCHOLOGICAL;

EID: 21544431881     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. P. L. Broadhurst, Behav. Genet., 5(4), 299-319 (1975).
2. T. L. Martin and J. M. Candy, Neuropharmacol., 17, 993-998(1978).
3. S. B. Seredenin and Yu. A. Blednov, A pharmacogenetic approach to the design of new selective, anxiolytic drugs, in: Seredenin S. B., Longo V., Gaviraghi G. (Eds) Biological Basis of individual Sensitivity to psychotripic drugs, Graffham Press Ltd. Edinburg, 25-38(1994)
4. S. B. Seredenin, Psychopharmacology & Biological Narcology, 1-2: 494-509 (2003).